Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...
News-Medical.Net18h
What can you do with a BioAFM instrument?
BioAFM instruments are designed to measure soft, fragile, and complex samples, including single molecules, nucleic acids, ...
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest ...
AZoNano17h
Can Nanoparticles Cross the Blood-Brain Barrier?
Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders through targeted drug delivery.
NBC Boston on MSN6h
Newton company aims to improve breast cancer detection in patients undergoing lumpectomies
A Massachusetts company is transforming the way breast cancer is detected in real time. Newton-based Lumicell launched its ...
National Hockey League13h
‘Panthers on the Prowl’ Statues for a Cause Launches in Conjunction with the American Cancer Society and Bill and Julie Zito
At a press conference at the Baptist Health IcePlex, the American Cancer Society (ACS) announced today the launch of ...